Develop, Partner, Acquire or Avoid – Where’s Investment for Digital Pathology Headed?

23rd January 2022 – Written by Imogen Fitt – Featured on PathologyNews.com

In December, Imogen Fitt of Signify Research attended the 9th Digital Pathology and AI Congress: Europe. In the article below she shares her thoughts on the conference with respect to recent industry discourse.

News of Fujifilm’s recent acquisition of software provider Inspirata’s digital pathology assets was met with much interest last month, following on from robust industry debate at Global Engage’s Digital Pathology and AI Congress: Europe a few weeks prior. There discussions centred around the progress of the market and its inevitable future developments.